Walter Reinisch, MD

Professor, Division of Gastroenterology, Department of Medicine

Chairholder, Audrey Campbell Chair in Ulcerative Colitis Research

Associate Professor, Gastroenterology, Division of Gastroenterology & Hepatology, Medical University of Vienna


Dr. Reinisch, MD, graduated at the Medical University of Vienna (MUV), where he finished his training in Internal Medicine and Gastroenterology. After initial scientific studies in oncology at the MUV and the National Cancer Institute, Frederick, MD, he decided to focus his research interest on inflammatory Bowel disease (IBD). Dr. Reinisch is founding member of the European Crohn’s & Colitis Organisation (ECCO) and was assigned as honorary member after having contributed in various positions. He was active in the Scientific and Public Affairs Committee of the United European Gastroenterology (UEG) and headed the Austrian IBD Study Group. Dr. Reinisch is member of the International Organization For the Study of Inflammatory Bowel Disease (IOIBD).

Dr. Reinisch is an expert in designing, conducting and interpreting the results of clinical trials in IBD. He envisions a customized management of IBD utilizing the innovations of translational medicine. He advocates the implementation of a “common language of inflammatory bowel disease” to improve the communication with patients and between physicians for a better care and more robust research outcomes.

  1. Willi, M, Yoo, KH, Reinisch, F, Kuhns, TM, Lee, HK, Wang, C et al.. Facultative CTCF sites moderate mammary super-enhancer activity and regulate juxtaposed gene in non-mammary cells. Nat Commun. 2017;8 :16069. doi: 10.1038/ncomms16069. PubMed PMID:28714474 .
  2. Reinisch, A, Malkomes, P, Habbe, N, Bechstein, WO, Liese, J. Bad bacteria in acute appendicitis: rare but relevant. Int J Colorectal Dis. 2017; :. doi: 10.1007/s00384-017-2862-0. PubMed PMID:28710611 .
  3. Bosker, HR, Reinisch, E. Foreign Languages Sound Fast: Evidence from Implicit Rate Normalization. Front Psychol. 2017;8 :1063. doi: 10.3389/fpsyg.2017.01063. PubMed PMID:28701977 PubMed Central PMC5487441.
  4. Kung, KTF, Li, G, Golding, J, Hines, M. Preschool Gender-Typed Play Behavior at Age 3.5 Years Predicts Physical Aggression at Age 13 Years. Arch Sex Behav. 2017; :. doi: 10.1007/s10508-017-1005-6. PubMed PMID:28646480 .
  5. Zuk, G, Reinisch, KB, Raptis, DA, Fertsch, S, Guggenheim, M, Palma, AF et al.. Dupuytren Disease: Is There Enough Comprehensive Patient Information on the Internet?. Interact J Med Res. 2017;6 (1):e7. doi: 10.2196/ijmr.7822. PubMed PMID:28642214 .
  6. Reinisch, A, Heil, J, Woeste, G, Bechstein, W, Liese, J. The meteorological influence on seasonal alterations in the course of acute appendicitis. J. Surg. Res. 2017; :. doi: 10.1016/j.jss.2017.05.015. PubMed PMID:28599958 .
  7. Sinha, S, Thomas, D, Chan, S, Gao, Y, Brunen, D, Torabi, D et al.. Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data. Nat Commun. 2017;8 :15580. doi: 10.1038/ncomms15580. PubMed PMID:28561042 PubMed Central PMC5460027.
  8. Vermeire, S, Sandborn, WJ, Danese, S, Hébuterne, X, Salzberg, BA, Klopocka, M et al.. Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet. 2017;390 (10090):135-144. doi: 10.1016/S0140-6736(17)30930-3. PubMed PMID:28527704 .
  9. Reinisch, W, Jahnsen, J, Schreiber, S, Danese, S, Panés, J, Balsa, A et al.. Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents. BioDrugs. 2017;31 (3):223-237. doi: 10.1007/s40259-017-0219-4. PubMed PMID:28497221 PubMed Central PMC5443869.
  10. Liese, J, Bottner, N, Büttner, S, Reinisch, A, Woeste, G, Wortmann, M et al.. Influence of the recipient body mass index on the outcomes after kidney transplantation. Langenbecks Arch Surg. 2017; :. doi: 10.1007/s00423-017-1584-7. PubMed PMID:28493145 .
Search PubMed
Share on FacebookTweet about this on TwitterShare on Google+Share on LinkedIn